PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Acute administration of 300 mg MLE (≥60% mangiferin) significantly increased performance in serial 3's and seri tasks compared to placebo in healthy adults [PMID:38665302]. Another study on soluble MLE (Zynamite S) at doses of 100-150 mg improved mental performance and mood in university students [PMID:40284006].
MLE administration (40 mg/kg) in diabetic rats significantly reduced fasting blood glucose, HbA1c, body weight, cholesterol, and triglycerides [PMID:41465578].
Acute treatment with MLE (250 mg/kg) or mangiferin (40 mg/kg) in rats fed a cafeteria diet increased SOD activity and reduced NFκB (p65) concentration in nuclear extracts [PMID:31334539].
Systematic review indicates mango leaf extract and mangiferin yield favorable effects on glycemic control and plasma lipid profiles [PMID:38137871].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 38137871 (2023) — Mangifera indica L., By-Products, and Mangiferin on Cardio-Metabolic and Other Health Conditions: A Systematic Review. · Life (Basel, Switzerland)
- 2.PMID: 31257318 (2019) — Effects of Benzophenones from Mango Leaves on Lipid Metabolism. · Chemical & pharmaceutical bulletin
- 3.PMID: 41465578 (2025) — Molecular Mechanisms and Antidiabetic Effects of Mango (Mangifera indica) Leaf Extract as a GLP-1 Analogue in Type 2 Diabetic Rats. · International journal of molecular sciences
- 4.PMID: 24515595 (2014) — Characterization of mango (Mangifera indica L.) transcriptome and chloroplast genome. · Plant molecular biology
- 5.PMID: 35959428 (2022)